Ignite Creation Date:
2025-12-24 @ 3:33 PM
Ignite Modification Date:
2026-01-31 @ 10:02 AM
Study NCT ID:
NCT04106492
Status:
TERMINATED
Last Update Posted:
2025-11-14
First Post:
2019-09-25
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase 1/2a Study of SQ3370 in Patients With Advanced Solid Tumors
Sponsor:
Shasqi, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Cancer | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Sarcoma | View |
| None | Cancer | View |
| None | Tumor | View |
| None | Soft Tissue Sarcoma | View |
| None | Solid Tumor | View |
| None | Doxorubicin | View |
| None | Intratumoral | View |
| None | Anthracycline | View |
| None | Phase 1 | View |
| None | Ovarian Cancer | View |
| None | Precision Oncology | View |
| None | Precision Chemotherapy | View |
| None | Local Cancer Therapy | View |
| None | Targeted Cancer Therapy | View |
| None | Uterine Cancer | View |
| None | Head and Neck Cancer | View |
| None | Lung Cancer | View |